DK0665853T3 - Multimere polyvalente antitrombotiske midler - Google Patents

Multimere polyvalente antitrombotiske midler

Info

Publication number
DK0665853T3
DK0665853T3 DK93924287T DK93924287T DK0665853T3 DK 0665853 T3 DK0665853 T3 DK 0665853T3 DK 93924287 T DK93924287 T DK 93924287T DK 93924287 T DK93924287 T DK 93924287T DK 0665853 T3 DK0665853 T3 DK 0665853T3
Authority
DK
Denmark
Prior art keywords
antithrombotic agents
cyclic peptides
including linear
platelet
specific binding
Prior art date
Application number
DK93924287T
Other languages
English (en)
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatide Inc filed Critical Diatide Inc
Application granted granted Critical
Publication of DK0665853T3 publication Critical patent/DK0665853T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93924287T 1992-10-02 1993-10-01 Multimere polyvalente antitrombotiske midler DK0665853T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95546692A 1992-10-02 1992-10-02
PCT/US1993/009387 WO1994007918A1 (en) 1992-10-02 1993-10-01 Multimeric polyvalent antithrombotic agents

Publications (1)

Publication Number Publication Date
DK0665853T3 true DK0665853T3 (da) 2002-11-04

Family

ID=25496861

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93924287T DK0665853T3 (da) 1992-10-02 1993-10-01 Multimere polyvalente antitrombotiske midler

Country Status (11)

Country Link
US (2) US5977064A (da)
EP (1) EP0665853B1 (da)
JP (1) JPH08502261A (da)
AT (1) ATE222264T1 (da)
AU (1) AU696206B2 (da)
CA (1) CA2145847A1 (da)
DE (1) DE69332203T2 (da)
DK (1) DK0665853T3 (da)
ES (1) ES2182833T3 (da)
WO (1) WO1994007918A1 (da)
ZA (1) ZA937300B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019958A (en) * 1991-02-08 2000-02-01 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
AU709306B2 (en) * 1992-04-30 1999-08-26 Cis Bio International Radiolabeled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
JPH08502261A (ja) * 1992-10-02 1996-03-12 ダイアテク，インコーポレイテッド 多重多価抗血栓症剤
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
CZ2002343A3 (cs) 1999-07-29 2002-08-14 Epix Medical, Inc. Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
TWI221406B (en) * 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
AR047692A1 (es) * 2003-07-10 2006-02-08 Epix Medical Inc Imagenes de blancos estacionarios
US20080267882A1 (en) * 2007-04-27 2008-10-30 Stanford University Imaging compounds, methods of making imaging compounds, methods of imaging, therapeutic compounds, methods of making therapeutic compounds, and methods of therapy
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
US20120076283A1 (en) 2010-09-23 2012-03-29 Ajmera Dinesh Predictive Customer Service Environment
US11080721B2 (en) 2012-04-20 2021-08-03 7.ai, Inc. Method and apparatus for an intuitive customer experience
WO2013181461A2 (en) 2012-06-01 2013-12-05 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
CN103665107B (zh) 2012-09-05 2017-07-14 上海晟顺生物科技有限公司 同时具溶血栓、清除自由基和血栓靶向功能的新颖化合物及其制备方法和用途
US20220380478A1 (en) 2019-07-01 2022-12-01 Tonix Pharma Holdings Limited Anti-cd154 antibodies and uses thereof
EP4274587A1 (en) 2021-01-06 2023-11-15 Tonix Pharma Limited Methods of inducing immune tolerance with modified anti-cd154 antibodies

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4792525A (en) * 1982-08-04 1988-12-20 La Jolla Cancer Research Foundation Tetrapeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
EP0274868A1 (en) * 1986-12-13 1988-07-20 A.s. Clausen, Kaldager & Co. Measuring apparatus
US4843647A (en) * 1987-08-31 1989-07-04 Burlington Industries, Inc. Cold weather system
WO1989005150A1 (en) * 1987-12-10 1989-06-15 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
AU3569189A (en) * 1988-04-29 1989-11-24 New England Deaconess Hospital Corporation Hybrid peptides and methods of their use
CA2000666C (en) * 1988-10-14 1996-07-09 Jeffrey Lawrence Finnan Method of making a free-flowing, spray-dried edible powder comprising an oil
FR2639232A1 (fr) * 1988-10-21 1990-05-25 Sanofi Sa Medicaments contenant une interleukine-2 glycosylee
ES2084688T3 (es) * 1988-12-20 1996-05-16 Jolla Cancer Res Found Conjugados de polipeptido-polimero para el tratamiento de heridas.
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
EP0410537A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
EP0410541A1 (en) * 1989-07-28 1991-01-30 Merck & Co. Inc. Fibrinogen receptor antagonists
CA2021951A1 (en) * 1989-07-28 1991-01-29 Ruth F. Nutt Fibrinogen receptor antagonists
CA2021952A1 (en) * 1989-07-28 1991-01-29 Ruth F. Nutt Fibrinogen receptor antagonists
DE3925962A1 (de) * 1989-08-05 1991-02-07 Thomson Brandt Gmbh Videorecorder mit bandstandsanzeige
FR2651077B1 (fr) * 1989-08-18 1994-06-10 Letourneur Gregoire Dispositif de traitement d'echo notamment acoustique dans une ligne telephonique
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
NZ235563A (en) * 1989-10-13 1993-04-28 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical composition
NZ235564A (en) * 1989-10-13 1993-10-26 Merck & Co Inc Fibrinogen receptor antagonist and pharmaceutical compositions
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
US5091542A (en) * 1990-03-09 1992-02-25 Hybritech Incorporated Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
DK0527798T3 (da) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
US5185433A (en) * 1990-04-09 1993-02-09 Centocor, Inc. Cross-linking protein compositions having two or more identical binding sites
US5298488A (en) * 1990-10-26 1994-03-29 Fuji Photo Film Co., Ltd. CM-chitin derivatives and use thereof
JP2745351B2 (ja) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 ペプチド誘導体及びその用途
JPH06509551A (ja) * 1991-04-05 1994-10-27 ジェネンテク，インコーポレイテッド Ｇｐ　ＩＩ↓ｂＩＩＩ↓ａに対する高い特異性を有する血小板凝集阻害剤
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
JPH08502261A (ja) * 1992-10-02 1996-03-12 ダイアテク，インコーポレイテッド 多重多価抗血栓症剤
AU7763194A (en) * 1994-06-16 1996-01-04 Nassif Haddad Building block

Also Published As

Publication number Publication date
ES2182833T3 (es) 2003-03-16
EP0665853A1 (en) 1995-08-09
DE69332203T2 (de) 2003-05-28
AU696206B2 (en) 1998-09-03
ATE222264T1 (de) 2002-08-15
DE69332203D1 (de) 2002-09-19
WO1994007918A1 (en) 1994-04-14
JPH08502261A (ja) 1996-03-12
US5977064A (en) 1999-11-02
US6150329A (en) 2000-11-21
CA2145847A1 (en) 1994-04-14
ZA937300B (en) 1995-03-30
AU5402694A (en) 1994-04-26
EP0665853B1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
DK0665853T3 (da) Multimere polyvalente antitrombotiske midler
ATE167896T1 (de) Aus mehreren domänen bestehende hämatopoese- stimulatoren
EA200000427A1 (ru) Терапевтические применения хинолиновых производных
NO2004008I1 (no) Patentets benevnelse
DE69807679T2 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DE69329877T2 (de) Von L Protein abgeleitete Immunoglobulin-bindende Proteine und deren anwendungen
AU7366687A (en) Coupling agents for radiolabeling proteins
DE69034261D1 (de) Antikörper gegen VLA-4
SE9201331D0 (sv) Protein l och hybridproteiner daerav
FI962958A (fi) Humanisoituja vasta-aineita leukosyyttitarttumismolekyyliä VLA-4 vastaan
GR3024489T3 (da)
FI961285A0 (fi) CD40:n vasta-aineita
DK564989D0 (da) Bindingsproteiner
ATE296312T1 (de) Metalkomplexbildner
DE69535501D1 (de) Identifikation, reinigung und verwendungen von leczymen und karbohydratliganden
DE229016T1 (de) Interleukin-2-zusammensetzungen.
NL300102I2 (nl) Specifieke chimere immunoglobuline voor bloedplaatjes.
ATE200866T1 (de) Lösung für die peritonealdialyse
ATE22899T1 (de) Antithrombin-heparin komplex.
CA2126182A1 (en) Humanized antibodies reactive with gpiib/iiia
DE3867718D1 (de) Einschlusskomplexe von dipyridamol und cyclodextrinen.
ATE95069T1 (de) Durch antikoerper und liganden bewirkte zielrichtung von differentiationsinduktoren auf tumorzellen.
ATE222927T1 (de) Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii)